PhRMA Pushing For Policies To Facilitate Outcomes-Based Pricing
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry group is promoting policy changes such as allowing broader communications with payers and a safe harbor for patient adherence programs that may help manufacturers and payers negotiate outcomes-based contracts for biopharma products.